TOBI is a prescription inhaled medication for cystic fibrosis patients whose lungs contain bacteria called Pseudomonas aeruginosa. TOBI has not been studied in patients under 6 years of age, in those with a lung function outside of a certain range, or in those whose lungs contain bacteria called Burkholderia cepacia. To find out if TOBI is right for you, speak to your doctor.
In clinical studies,* patients taking TOBI had:
*These studies compared people taking TOBI versus placebo.
It is important to take TOBI twice a day as prescribed by your doctor, even if you feel healthy.
TOBI. Available to treat Pseudomonas aeruginosa in the lungs of people with CF for over a decade.